These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 35869803

  • 41. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA, Nguyen KL, Pham MH, Vi TT, Do NA.
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [Abstract] [Full Text] [Related]

  • 42. Cladophialophora carrionii: a rare agent of chromoblastomycosis in Rio de Janeiro State, Brazil.
    Mouchalouat Mde F, Galhardo MC, Fialho PC, Coelho JM, Zancopé-Oliveira RM, Valle AC.
    Rev Inst Med Trop Sao Paulo; 2008 Feb; 50(6):351-3. PubMed ID: 19082378
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean] [Natural history of chromoblastomycosis in Madagascar and the [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean].
    Esterre P, Andriantsimahavandy A, Raharisolo C.
    Bull Soc Pathol Exot; 1997 Feb; 90(5):312-7. PubMed ID: 9507759
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine.
    Sevigny GM, Ramos-Caro FA.
    Cutis; 2000 Jul; 66(1):45-6. PubMed ID: 10916691
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
    Najafzadeh MJ, Rezusta A, Cameo MI, Zubiri ML, Yus MC, Badali H, Revillo MJ, De Hoog GS.
    Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
    [Abstract] [Full Text] [Related]

  • 50. Chromoblastomycosis.
    Torres-Guerrero E, Isa-Isa R, Isa M, Arenas R.
    Clin Dermatol; 2012 Mar; 30(4):403-8. PubMed ID: 22682188
    [Abstract] [Full Text] [Related]

  • 51. Resazurin to determine the minimum inhibitory concentration on antifungal susceptibility assays for Fonsecaea sp. using a modified EUCAST protocol.
    Herman TS, da Silva Goersch C, Bocca AL, Fernandes L.
    Braz J Microbiol; 2024 Jun; 55(2):1349-1357. PubMed ID: 38438831
    [Abstract] [Full Text] [Related]

  • 52. Chromoblastomycosis: clinical and mycologic experience of 51 cases.
    Bonifaz A, Carrasco-Gerard E, Saúl A.
    Mycoses; 2001 Jun; 44(1-2):1-7. PubMed ID: 11398635
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine.
    Shen XC, Dai XN, Xie ZM, Li P, Lu S, Li JH, Zhang Y, Ye XD.
    Dermatol Ther (Heidelb); 2020 Apr; 10(2):321-327. PubMed ID: 32086748
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.